Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation
- PMID: 11071489
- DOI: 10.1212/wnl.55.8.1122
Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation
Abstract
Objective: To characterize the phenotypes of patients with juvenile and adult-onset acid maltase deficiency (AMD) in the French population and correlate them with genetic defects.
Background: AMD is an autosomal recessive disorder caused by the absence of the enzyme acid a-glucosidase (GAA). Patients are generally compound heterozygotes for various mutations in the GAA gene. The most common mutant allele is a -13T to G transversion in intron 1.
Methods: The authors performed a clinical, biochemical, and genetic study on 21 unrelated patients with juvenile and adult-onset AMD.
Results: Although onset of progressive muscle weakness occurred during adulthood in all cases but one, presence of mild, nonprogressive muscular symptoms appearing during childhood was detected in 16 patients. Eighteen patients had a similar clinical pattern with pelvic girdle muscle weakness predominating in glutei and thigh adductors. Restrictive respiratory insufficiency with vital capacity less than 60% was noted in eight patients, and respiratory failure was the first manifestation in two cases. All patients but one were compound heterozygotes, and 17 carried the IVS1 (-13T ---> G) transversion (one patient was homozygous for this mutation). The two mutated alleles were identified in 10 cases, with 13 different mutations detected in the GAA gene. There was no clear correlation between the type of mutation and phenotype.
Conclusions: This study shows a high genetic heterogeneity of juvenile and adult AMD in the French population. The absence of genotype-phenotype correlation suggests a complex physiopathology that requires further investigations.
Comment in
-
Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation.Neurology. 2001 Nov 27;57(10):1938. doi: 10.1212/wnl.57.10.1938. Neurology. 2001. PMID: 11723305 No abstract available.
Similar articles
-
Genotype-phenotype correlation in adult-onset acid maltase deficiency.Ann Neurol. 1995 Sep;38(3):450-4. doi: 10.1002/ana.410380316. Ann Neurol. 1995. PMID: 7668832
-
Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.Neurology. 2007 Jan 9;68(2):110-5. doi: 10.1212/01.wnl.0000252798.25690.76. Neurology. 2007. PMID: 17210890
-
Glycogen-storage disease type II (acid maltase deficiency): identification of a novel small deletion (delCC482+483) in French patients.Biochem Biophys Res Commun. 1997 Jun 9;235(1):138-41. doi: 10.1006/bbrc.1997.6749. Biochem Biophys Res Commun. 1997. PMID: 9196050
-
Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: a northern Italy population study and review of the literature.J Neurol. 2014 Jan;261(1):83-97. doi: 10.1007/s00415-013-7137-2. Epub 2013 Oct 25. J Neurol. 2014. PMID: 24158270 Review.
-
The genotype-phenotype correlation in Pompe disease.Am J Med Genet C Semin Med Genet. 2012 Feb 15;160C(1):59-68. doi: 10.1002/ajmg.c.31318. Epub 2012 Jan 17. Am J Med Genet C Semin Med Genet. 2012. PMID: 22253258 Review.
Cited by
-
Bulbar muscle impairment in patients with late onset Pompe disease: Insight from the French Pompe registry.Eur J Neurol. 2024 Oct;31(10):e16428. doi: 10.1111/ene.16428. Epub 2024 Aug 7. Eur J Neurol. 2024. PMID: 39109844 Free PMC article.
-
Recent advances in clinical neurogenetics.J Neurol. 2013 Oct;260(10):2451-7. doi: 10.1007/s00415-012-6757-2. Epub 2012 Nov 16. J Neurol. 2013. PMID: 23161463 Review.
-
Safety and efficacy of exercise training in adults with Pompe disease: evalution of endurance, muscle strength and core stability before and after a 12 week training program.Orphanet J Rare Dis. 2015 Jul 19;10:87. doi: 10.1186/s13023-015-0303-0. Orphanet J Rare Dis. 2015. PMID: 26187632 Free PMC article.
-
Extent, impact, and predictors of diagnostic delay in Pompe disease: A combined survey approach to unveil the diagnostic odyssey.JIMD Rep. 2019 Jul 17;49(1):89-95. doi: 10.1002/jmd2.12062. eCollection 2019 Sep. JIMD Rep. 2019. PMID: 31497486 Free PMC article.
-
Enzyme replacement therapy for Pompe disease.Curr Neurol Neurosci Rep. 2012 Feb;12(1):70-5. doi: 10.1007/s11910-011-0236-5. Curr Neurol Neurosci Rep. 2012. PMID: 22002767 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous